FDA.reportPublic FDA data

Device Listing 1342377202

Listing Summary#

Listing key
1342377202
Premarket submission
K130010
Device
PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Applicant
Nanostring Technologies
Product code
NYI
Decision date
2013-09-06